GACM
BMRN icon

Green Arrow Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Green Arrow Capital Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-130,000
Closed -$9.38M – 133
2014
Q3 		$9.38M Buy
130,000
+80,000
+160% +$5.26M 0.79% 31
2014
Q2 		$3.11M Buy
50,000
+10,000
+25% +$604K 0.39% 74
2014
Q1 		$2.73M Sell
40,000
-37,071
-48% -$2.73M 0.23% 135
2013
Q4 		$5.42M Buy
+77,071
New +$5.23M 0.38% 93
2013
Q3 		– Sell
-125,000
Closed -$6.97M – 259
2013
Q2 		$6.97M Buy
+125,000
New +$7.79M 0.56% 44

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return